Buzz Stocks: ACADIA Pharmaceuticals Inc., Tesla Motors Inc, and Millennial Media, Inc.

Today's stocks to watch include ACADIA Pharmaceuticals Inc. (ACAD), Tesla Motors Inc (TSLA), and Millennial Media, Inc. (MM)

by Mark Fightmaster

Published on Sep 3, 2015 at 10:31 AM

The Dow is higher this morning, as it makes a run at a second straight positive session. Among the equities in focus are drugmaker ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), automaker Tesla Motors Inc (NASDAQ:TSLA), and mobile advertiser Millennial Media, Inc. (NYSE:MM).

  1. ACAD is 10.4% higher at $42.01, after the pharmaceutical firm submitted a new drug application to the U.S. Food and Drug Administration for NUPLAZID -- a treatment for psychosis associated with Parkinson's. According to newly minted CEO Steve Davis, NUPLAZID "holds promise for patients with Parkinson's disease psychosis who currently have no FDA-approved treatment options." ACAD has now advanced roughly 32.5% in 2015, and is trading above its 10-week trendline for the first time since late July. Despite this performance, short interest is high, with 17% of the equity's float sold short. It would take roughly 8.5 days to exhaust this surplus of shorted shares, at ACADIA Pharmaceuticals Inc.'s average pace of trading, so we could see the shares enjoy a short-covering rally.

Get the skinny on all the biggest stories of the morning… Sign up now to get Schaeffer's Midday Market Check delivered straight to your inbox!


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.
Patent Lawsuit Loss Sends AMRN Stock Spiraling
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa
RH Stock Sinks Despite Earnings Beat
J.P. Morgan Securities and Cowen and Company cut their price targets
The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.